ME 23andMe Holding Co.
Healthcare$0.61+0.00%ClosedMarket Cap: $15.3M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.51
P/S
0.12
EV/EBITDA
-0.03
DCF Value
$-164.55
FCF Yield
-766.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
54.2%
Operating Margin
-105.7%
Net Margin
-134.7%
ROE
-770.8%
ROA
-122.1%
ROIC
-212.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $25.4M | 53.2% | $-30.7M | $-23.8M | $— | — |
| Q4 null | $45.1M | 38.8% | $-98.6M | $-99.3M | $— | — |
| FY null | $189.9M | 52.7% | $-240.6M | $-280.9M | $— | — |
| Q3 null | $60.3M | 66.1% | $-8.9M | $-53.0M | $— | — |
| Q2 null | $44.1M | 50.8% | $-61.2M | $-59.1M | $— | — |
| Q1 null | $40.4M | 50.8% | $-72.0M | $-69.4M | $— | — |
| Q4 null | $64.0M | 42.2% | $-58.9M | $-208.8M | $— | — |
| FY null | $219.6M | 45.2% | $-321.4M | $-666.7M | $— | — |
| Q3 null | $44.7M | 44.6% | $-80.9M | $-278.0M | $— | — |
| Q2 null | $50.0M | 43.5% | $-79.1M | $-75.3M | $— | — |
| Q1 2023 | $60.9M | 50.4% | $-109.3M | $-104.6M | $-4.53 | — |
| Q4 2022 | $92.4M | 43.3% | $-69.3M | $-64.1M | $-2.81 | — |